Inhibition of Pseudomonas aeruginosa Biofilm Formation by Peptidyl-Arginine Deiminases 2 and 4
Journal of Innate Immunity · 2026
DOI: 10.1159/000550256 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Innate Immunity, 2026. Verfasst von Rory Baird und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pulmonary Clinical Science, Department of Anaesthesia and Critical Care Medicine, RCSI University of Medicine and Health Sciences, Beaumont Hospital,…. Hauptthemen laut MEDLINE: Biofilms, Pseudomonas aeruginosa, Pseudomonas Infections, Protein-Arginine Deiminase Type 2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Pseudomonas aeruginosa is a significant pathogen associated with acute and chronic infections, particularly in immunocompromised individuals. Its capacity for biofilm formation, combined with antibiotic resistance, plays a critical role in the persistence of these infections. Peptidyl-arginine deiminases (PADs), including PAD2 and PAD4 isoforms, are involved in neutrophil phagocytic killing of P. aeruginosa. This study aimed to investigate the impact of PAD enzymes on biofilm development and virulence factor production in P. aeruginosa, with focus on the multidrug resistant strain, PGO2330.
Methods
Biofilm formation was assessed using crystal violet assays and confocal scanning laser microscopy. Quorum sensing (QS) gene expression and QS-related virulence factor production were quantified using qPCR and virulence factor assays.
Results
Exposure to 20 nm of PAD2 or PAD4 reduced PGO2330 surface attachment (p < 0.0001) and biofilm formation to 67.9 ± 5.6% (p < 0.0001) and 68.2 ± 4.2% (p = 0.0004), respectively. Moreover, rPAD2 and rPAD4 citrullinated multiple protein substrates of P. aeruginosa, yet citrullination activity was not required by rPADs to reduce P. aeruginosa biofilm formation. PGO2330 exposed to PAD2 and PAD4 showed reduced lasR, lasI, rhlR, rhlI, and mvfR gene expression and reduced levels of extracellular DNA, rhamnolipids, pyocyanin, and protease activity.
Conclusion
These results demonstrate that PADs inhibit P. aeruginosa biofilm formation and decrease the production of QS-related virulence factors, highlighting their potential as novel antimicrobials and supporting further research into the development of PAD-based therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pulmonary Clinical Science, Department of Anaesthesia and Critical Care Medicine, RCSI University of Medicine and Health Sciences, Beaumont Hospital, Dublin, Ireland, rorybaird22@rcsi.ie.
- Pulmonary Clinical Science, Department of Anaesthesia and Critical Care Medicine, RCSI University of Medicine and Health Sciences, Beaumont Hospital, Dublin, Ireland.
- Cellular and Molecular Imaging Core, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
- Department of Clinical Microbiology, Royal College of Surgeons in Ireland, Dublin, Ireland.
- Department of Microbiology, Beaumont Hospital, Dublin, Ireland.
Zitieren
APA
Baird, R., Gogoi, D., Forde, L., Ahmed, S. W., Niu, M., Cavanagh, B., Fitzpatrick, F., & Reeves, E. P. (2026). Inhibition of Pseudomonas aeruginosa Biofilm Formation by Peptidyl-Arginine Deiminases 2 and 4. Journal of Innate Immunity. https://doi.org/10.1159/000550256
Vancouver
Baird R, Gogoi D, Forde L, Ahmed SW, Niu M, Cavanagh B, et al. Inhibition of Pseudomonas aeruginosa Biofilm Formation by Peptidyl-Arginine Deiminases 2 and 4. Journal of Innate Immunity. 2026. doi:10.1159/000550256
BibTeX
@article{Baird2026,
author = {Baird, Rory and Gogoi, Debananda and Forde, Luke and Ahmed, Sara Waqas and Niu, Mengxin and Cavanagh, Brenton and Fitzpatrick, Fidelma and Reeves, Emer P},
title = {Inhibition of Pseudomonas aeruginosa Biofilm Formation by Peptidyl-Arginine Deiminases 2 and 4},
journal = {Journal of Innate Immunity},
year = {2026},
doi = {10.1159/000550256}
}
EUVIMED